Freshfields advised Evotec on the deal. Evotec SE was granted an unsecured €150 million loan facility provided by the European Investment Bank (‘EIB’). The EIB...
Evotec’s €150 Million Unsecured Loan Facility by EIB
Evotec’s Acquisition of Central Glass Germany
Arqis advised Central Glass, while Freshfields Bruckhaus Deringer advised Evotec SE. Evotec SE announced the acquisition of Central Glass Germany GmbH from Japanese chemical manufacturing company...
Evotec’s Partnership with Sernova
Torys LLP acted as counsel to Evotec. On May 17, 2022, Evotec SE and Sernova Corp. announced a partnership in the field of diabetes. Both Companies will leverage...
Evotec’s €23 Million Acquisition of Rigenerand
Freshfields Bruckhaus Deringer advised Evotec SE. DLA Piper has advised Xyence Capital SGR, Rigenand’s majority shareholder. Watson Farley & Williams supported the dissemination of minority shareholders....
Tubulis’ €60 Million Series B Financing Round
CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B...
Centauri Therapeutics’ $32 Million Series A Investment
Goodwin advised BIVF, Novo and Evotec on the deal. Boehringer Ingelheim Venture Fund GmbH (“BIVF”), Novo Holdings REPAIR Impact Fund (“Novo”) and Evotec SE (“Evotec”) led...
Aptuit Srl’s Acquisition of R&D Center from GlaxoSmithKline
IN BRIEF: CBA, Macchi Di Cellere Gangemi, advised on the matter. CBA advised Glaxo Group Limited, Glaxosmithkline Finance Plc, Glaxosmithkline Research & Development Limited, Setfirst Limited...